Nairne Scott‐Douglas

Overview of the Alberta Kidney Disease Network

Fiona Clement, Braden Manns, Scott Klarenbach et al. · BMC Nephrology · 2009 · 265 citations · Full text

Medicine, Health Informatics, Nephrology +14

Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator

Brenda R. Hemmelgarn, Louise Moist, Charmaine E. Lok et al. · New England Journal of Medicine · 2011 · 208 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

Braden Manns, Ellen Burgess, M. Eric Hyndman et al. · American Journal of Kidney Diseases · 1999 · 83 citations

Medicine, Cardiology, Nephrology +13

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study

Maoliosa Donald, Kathryn King‐Shier, Ross T. Tsuyuki et al. · CMAJ Open · 2017 · 69 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +17

Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients

Braden Manns, Ellen Burgess, Howard G. Parsons et al. · Kidney International · 1999 · 66 citations · Full text

Medicine, Hematology, Nephrology +16